Publications by authors named "Craig Gibbs"

Claim this Profile
C
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus.
Francesco Andreata, Kelly D Moynihan, Valeria Fumagalli, Pietro Di Lucia, Danielle C Pappas, Craig S Gibbs

Sci Transl Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in HIV-1 reverse transcriptase resistance-associated mutations and antiretroviral prescription data from 2003-2010.
Michael D Miller, Mojgan Haddad, Cathy Su, Craig Gibbs, Damian J McColl

Antivir Ther· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR studies on dihydropyrimidinone antibiotics.
Lianhong Xu, Lijun Zhang, Robert Jones, Clifford Bryant, Nina Boddeker, Craig Gibbs

Bioorg Med Chem Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimat.
Nicolas A Margot, Craig S Gibbs, Michael D Miller

Antimicrob Agents Chemother· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cathepsin A is the major hydrolase catalyzing the intracellular hydrolysis of the antiretroviral nucleotide phosphonoamidate prodrugs GS-7340 and GS-9131.
Gabriel Birkus, Ruth Wang, Xiaohong Liu, Nilima Kutty, Holly MacArthur, Craig Gibbs

Antimicrob Agents Chemother· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin.
Qing Guo, Yuequan Shen, Young-Sam Lee, Craig S Gibbs, Milan Mrksich

EMBO J· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro.
William E Delaney, Huiling Yang, Michael D Miller, Craig S Gibbs, Shelly Xiong

Antimicrob Agents Chemother· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery.
Wendy J Carter, Timothy Myles, Craig S Gibbs, Lawrence L Leung, James A Huntington

J Biol Chem· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.
Bettina Werle-Lapostolle, Scott Bowden, Stephen Locarnini, Karsten Wursthorn, Jorg Petersen, Craig S Gibbs

Gastroenterology· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir.
Steve Tuske, Stefan G Sarafianos, Arthur D Clark, Jianping Ding, Lisa K Naeger, Craig S Gibbs

Nat Struct Mol Biol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of hepatitis B virus dynamics and its impact on antiviral development.
Manuel Tsiang, Craig S Gibbs

Methods Mol Med· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection.
Yuequan Shen, Natalia L Zhukovskaya, Michael I Zimmer, Sandriyana Soelaiman, Pamela Bergson, Craig S Gibbs

Proc Natl Acad Sci U S A· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.
Jean-Pierre Villeneuve, David Durantel, Sandra Durantel, Christopher Westland, Shelly Xiong, Craig S Gibbs

J Hepatol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro.
William E Delaney, Huiling Yang, Christopher E Westland, Kalyan Das, Eddy Arnold, Craig S Gibbs

J Virol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.
Peter Angus, Rhys Vaughan, Shelly Xiong, Huiling Yang, William Delaney, Craig Gibbs

Gastroenterology· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B.
Christopher E Westland, Huiling Yang, William E Delaney, Craig S Gibbs, Michael D Miller

Hepatology· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1.
Chris Westland, William Delaney, Huiling Yang, Shan-Shan Chen, Patrick Marcellin, Craig Gibbs

Gastroenterology· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.
Franck Le Guerhier, Alexandre Thermet, Sylvianne Guerret, Michèle Chevallier, Catherine Jamard, Craig S Gibbs

J Hepatol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical characterization of rhinovirus RNA-dependent RNA polymerase.
Magdeleine Hung, Craig S Gibbs, Manuel Tsiang

Antiviral Res· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a novel antibacterial agent that inhibits bacterial translation.
Nina Böddeker, Gina Bahador, Craig Gibbs, Eric Mabery, John Wolf

RNA· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks.
Huiling Yang, Christopher E Westland, William E Delaney, Elizabeth J Heathcote, Victoria Ho, Craig S Gibbs

Hepatology· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.
Julien Delmas, Olivier Schorr, Catherine Jamard, Craig Gibbs, Christian Trépo

Antimicrob Agents Chemother· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV.
Maurizio Bonacini, Alan Kurz, Stephen Locarnini, Anna Ayres, Craig Gibbs

Gastroenterology· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis